This is a Validated Antibody Database (VAD) review about rat Ctla4, based on 7 published articles (read how Labome selects the articles), using Ctla4 antibody in all methods. It is aimed to help Labome visitors find the most suited Ctla4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ctla4 synonym: CTLA-4; Cd152; sCTLA4
Santa Cruz Biotechnology
mouse monoclonal (F-8) |
| Santa Cruz Biotechnology Ctla4 antibody (Santa Cruz Biotechnology, sc-376016) was used in immunohistochemistry on mouse samples at 1:5000 (fig 7d). JCI Insight (2020) ncbi |
mouse monoclonal (F-8) |
| Santa Cruz Biotechnology Ctla4 antibody (Santa Cruz, sc-376016) was used in flow cytometry on mouse samples (fig 1b). Braz J Med Biol Res (2016) ncbi |
mouse monoclonal (F-8) |
| Santa Cruz Biotechnology Ctla4 antibody (Santa Cruz, sc-376016) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 3c). J Immunol Res (2016) ncbi |
mouse monoclonal (F-8) |
| Santa Cruz Biotechnology Ctla4 antibody (Santa Cruz, SC-376016) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). Breast Cancer Res (2016) ncbi |
mouse monoclonal (F-8) |
| In order to test if atypical fibroxanthoma is the non-infiltrating precursor lesion of pleomorphic dermal sarcoma, Santa Cruz Biotechnology Ctla4 antibody (Santa Cruz, sc-376016) was used in immunohistochemistry - paraffin section on human samples at 1:400 (tbl 4). Oncotarget (2016) ncbi |
BioLegend
mouse monoclonal (WKH203) |
| BioLegend Ctla4 antibody (BioLegend, WKH203) was used in flow cytometry on rat samples (fig 3). Eur J Immunol (2015) ncbi |
Abcam
domestic rabbit monoclonal (EPR1476) |
| In order to determine the induction of liver injury in mice due to molecular circuits of diclofenac revealed by immunogenomics, Abcam Ctla4 antibody (Abcam, ab134090) was used in western blot on mouse samples (fig 12). Oncotarget (2016) ncbi |
Articles Reviewed
- Kaewkangsadan V, Verma C, Eremin J, Cowley G, Ilyas M, Eremin O. Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer. J Immunol Res. 2016;2016:4757405 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments